{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:36:58Z","timestamp":1765539418953,"version":"3.48.0"},"reference-count":11,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,17]]},"DOI":"10.1515\/jbcpp-2021-0334","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:51:50Z","timestamp":1639011110000},"page":"117-119","source":"Crossref","is-referenced-by-count":6,"title":["Using of calcium channel blockers in patients with COVID-19: a magic bullet or a double-edged sword?"],"prefix":"10.1515","volume":"33","author":[{"given":"Sonia","family":"Sadeghpopur","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynecology , School of Medicine, Urmia University of Medical Sciences , Urmia , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojat","family":"Ghasemnejad-Berenji","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Histology and Reproductive Biology , School of Medicine, Shahid Beheshti University of Medical Sciences , Tehran , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarvin","family":"Pashapour","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , School of Medicine, Urmia University of Medical Sciences , Urmia , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Ghasemnejad-Berenji","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology , Faculty of Pharmacy, Urmia University of Medical Sciences , Urmia , Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_001","doi-asserted-by":"crossref","unstructured":"Jafari, A, Sadeghpour, S, Ghasemnejad-Berenji, H, Pashapour, S, Ghasemnejad-Berenji, M. Potential antioxidative, anti\u2010inflammatory and immunomodulatory effects of ghrelin, an endogenous peptide from the stomach in SARS-CoV2 infection. Int J Pept Res Therapeut 2021;27:1875\u20131883. https:\/\/doi.org\/10.1007\/s10989-021-10217-9.","DOI":"10.1007\/s10989-021-10217-9"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_002","doi-asserted-by":"crossref","unstructured":"Ghasemnejad-Berenji, M, Pashapour, S, Ghasemnejad-Berenji, H. Therapeutic potential for clomiphene, a selective estrogen receptor modulator, in the treatment of COVID\u201019. Med Hypotheses 2020;145:110354. https:\/\/doi.org\/10.1016\/j.mehy.2020.110354.","DOI":"10.1016\/j.mehy.2020.110354"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_003","doi-asserted-by":"crossref","unstructured":"Chen, X, Cao, R, Zhong, W. Host calcium channels and pumps in viral infections. Cells 2020;9:94. https:\/\/doi.org\/10.3390\/cells9010094.","DOI":"10.3390\/cells9010094"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_004","doi-asserted-by":"crossref","unstructured":"Neuraz, A, Lerner, I, Digan, W, Paris, N, Tsopra, R, Rogier, A, et al.. Natural language processing for rapid response to emergent diseases: case study of calcium channel blockers and hypertension in the COVID-19 pandemic. J Med Internet Res 2020;22:e20773. https:\/\/doi.org\/10.2196\/20773.","DOI":"10.2196\/20773"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_005","doi-asserted-by":"crossref","unstructured":"Soleymani, S, Zabihollahi, R, Shahbazi, S, Bolhassani, A. Antiviral effects of saffron and its major ingredients. Curr Drug Deliv 2018;15:698\u2013704. https:\/\/doi.org\/10.2174\/1567201814666171129210654.","DOI":"10.2174\/1567201814666171129210654"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_006","doi-asserted-by":"crossref","unstructured":"Zhang, L-K, Sun, Y, Zeng, H, Wang, Q, Jiang, X, Shang, WJ, et al.. Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell Discov 2020;6:1\u201312. https:\/\/doi.org\/10.1038\/s41421-020-00235-0.","DOI":"10.1038\/s41421-020-00235-0"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_007","doi-asserted-by":"crossref","unstructured":"Bultynck, G, Parys, JB. Ca2+ signaling and cell death: focus on Ca2+-transport. Mol Cell 2017;66:780\u20138.","DOI":"10.1016\/j.molcel.2017.05.028"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_008","doi-asserted-by":"crossref","unstructured":"Piacentini, R, Civitelli, L, Ripoli, C, Marcocci, ME, De Chiara, G, Garaci, E, et al.. HSV-1 promotes Ca2+-mediated APP phosphorylation and A\u03b2 accumulation in rat cortical neurons. Neurobiol Aging 2011;32:2323. e13\u201326. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.06.009.","DOI":"10.1016\/j.neurobiolaging.2010.06.009"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_009","doi-asserted-by":"crossref","unstructured":"Alam, M, Mostafa, A, Kanrai, P, M\u00fcller, C, Dzieciolowski, J. Verapamil has antiviral activities that target different steps of the influenza virus replication cycle. J Antivir Antiretrovir 2016;8:121\u201330. https:\/\/doi.org\/10.4172\/jaa.1000147.","DOI":"10.4172\/jaa.1000147"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_010","doi-asserted-by":"crossref","unstructured":"Straus, MR, Bidon, M, Tang, T, Whittaker, G, Daniel, S. FDA approved calcium channel blockers inhibit SARS-CoV-2 infectivity in epithelial lung cells. bioRxiv 2020. https:\/\/doi.org\/10.1101\/2020.07.21.214577.","DOI":"10.1101\/2020.07.21.214577"},{"key":"2025121209055370913_j_jbcpp-2021-0334_ref_011","doi-asserted-by":"crossref","unstructured":"Mendez, SR, Frank, RC, Stevenson, EK, Chung, M, Silverman, MG. Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19. Chest 2021;160:89\u201393. https:\/\/doi.org\/10.1016\/j.chest.2021.01.073.","DOI":"10.1016\/j.chest.2021.01.073"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2021-0334\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2021-0334\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:33:58Z","timestamp":1765539238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2021-0334\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,9,13]]},"published-print":{"date-parts":[[2022,1,17]]}},"alternative-id":["10.1515\/jbcpp-2021-0334"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2021-0334","relation":{},"ISSN":["0792-6855","2191-0286"],"issn-type":[{"type":"print","value":"0792-6855"},{"type":"electronic","value":"2191-0286"}],"subject":[],"published":{"date-parts":[[2021,12,8]]}}}